Overview Insulin Glargine at Bedtime or in AM Versus NPH Status: Completed Trial end date: 2009-08-01 Target enrollment: Participant gender: Summary To compare the efficacy and safety of once-nightly insulin glargine versus a single morning injection of glargine or once-nightly NPH insulin in ethnic minority type 2 diabetic patients inadequately controlled on combination oral agents. Phase: Phase 4 Details Lead Sponsor: Charles Drew University of Medicine and ScienceCollaborator: National Center for Research Resources (NCRR)Treatments: InsulinInsulin GlargineInsulin, Globin ZincInsulin, IsophaneIsophane insulin, beefIsophane Insulin, Human